A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity
Nucleic Acids Research · 08.06.2026 · 54 (11)
DOI: 10.1093/nar/gkag588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 11.06.2026. Verfasst von Anna Ligasová und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, 779 00 Olomouc, Czec…. Hauptthemen laut MEDLINE: Cytidine Deaminase, RNA, Enzyme Assays. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic, Technology Agency of the Czech Republic, Ministry of Education, Youth and Sports of the Czech Republic.
Abstract (Originalsprache)
We developed a robust, hybrid RNA-based reporter assay for the quantification of cytidine deaminase (CDA) activity, overcoming limitations of current methods often compromised by interferences in crude biological samples. Our two-step method physically separates the enzymatic reaction in cell lysates from a highly specific detection step in a selected and validated CDA-deficient reporter cell line (143B cell line). This design confers exceptional robustness, eliminating the need for sample purification. In the first step, a cell lysate converts 5-fluorocytidine to 5-fluorouridine. After heat inactivation of lysate proteins, 5-fluorouridine is quantified by its incorporation into reporter cell RNA, yielding a highly specific fluorescent signal. The detection limit of a formed product in the assay achieves 2.7 µM. The assay shows good correlation with LC-MS data, and its adaptability to a multi-well plate format makes it an ideal and cost-effective tool for high-throughput screening. We further applied this assay to reveal that CDA-positive cells actively secrete 5-fluorouridine, providing quantitative evidence for a potential therapeutic bystander effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, 779 00 Olomouc, Czech Republic.
- Laboratory of Inherited Metabolic Disorders, Department of Clinical Chemistry, University Hospital Olomouc, Zdravotníků 248/7, 779 00 Olomouc, Czech Republic.
- Institute of Pathological Physiology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 53 Prague 2, Czech Republic.
ORCID-Profile: Anna Ligasová
Förderung
- Ministry of Health of the Czech Republic
- Technology Agency of the Czech Republic
- Ministry of Education, Youth and Sports of the Czech Republic
- European Union
Zitieren
APA
Ligasová, A., Horejšová, M., Friedecký, D., Pokorná, E., Klener, P., & Koberna, K. (2026). A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity. Nucleic Acids Research, 54(11). https://doi.org/10.1093/nar/gkag588
Vancouver
Ligasová A, Horejšová M, Friedecký D, Pokorná E, Klener P, Koberna K. A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity. Nucleic Acids Research. 2026;54(11). doi:10.1093/nar/gkag588
BibTeX
@article{Ligasov2026,
author = {Ligasová, Anna and Horejšová, Martina and Friedecký, David and Pokorná, Eva and Klener, Pavel and Koberna, Karel},
title = {A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {11},
doi = {10.1093/nar/gkag588}
}
EUVIMED